Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D98UXE
|
|||
| Drug Name |
NNZ-2256
|
|||
| Indication | Fragile X syndrome [ICD-11: LD55; ICD-10: Q99.2] | Phase 2 | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01894958 ) A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.